You just read:

Exploratory Efficacy Analysis Conducted for Long-Term Extension Study in Patients With Prostate Cancer Treated With FIRMAGON® or Crossed Over to FIRMAGON From Leuprolide

News provided by

Ferring Pharmaceuticals Inc.

May 16, 2011, 11:02 ET